How Credo Life Sciences Excels as a Pharmaceutical Pellets Manufacturing Company

The Science Behind Pharmaceutical Pellet Manufacturing

Pharmaceutical pellets are small, spherical or semi-spherical solid dosage units ranging from 0.5–2.0 mm in diameter. They are manufactured through techniques such as drug layering onto starter beads, extrusion-spheronisation, and hot melt extrusion. Their multi-particulate structure offers significant advantages including predictable pharmacokinetics, reduced risk of dose dumping, and the ability to combine incompatible APIs in a single capsule. Producing high-quality pellets requires advanced process control and deep expertise in polymer science and formulation engineering.

State-of-the-Art Manufacturing Infrastructure at Credo Life Sciences

Credo Life Sciences operates a modern GMP-compliant manufacturing facility equipped with advanced pelletisation technologies including fluid bed processors with Wurster, top-spray, and tangential spray configurations, extrusion-spheronisation systems, and precision coating equipment. The facility also incorporates Process Analytical Technology (PAT) tools for real-time monitoring and process optimisation, ensuring consistent batch quality and manufacturing precision.

Diverse Pellet Portfolio Serving Multiple Therapeutic Areas

Enteric-Coated Pellets

Enteric-coated pellets are designed to protect acid-sensitive drugs from degradation in the stomach while ensuring release in the intestinal tract. These pellets are widely used for proton pump inhibitors including Omeprazole, Esomeprazole, Pantoprazole, and Dexlansoprazole.

Extended-Release Pellets

Extended-release pellets are engineered to deliver controlled drug release over periods ranging from 8 to 24 hours. Credo Life Sciences utilises advanced membrane coating technologies with polymers such as ethylcellulose and Eudragit RS/RL to achieve precise dissolution profiles for products including Tamsulosin, Venlafaxine HCl, and Galantamine.

Taste-Masked and Immediate-Release Pellets

Taste-masking technologies improve patient compliance by concealing the bitterness of active pharmaceutical ingredients, while immediate-release pellets ensure rapid dissolution and fast therapeutic action. Credo Life Sciences develops customised coating systems tailored to specific formulation and patient requirements.

Quality Control and Regulatory Excellence

Every production batch at Credo Life Sciences undergoes comprehensive quality testing including dissolution profiling, friability testing, moisture analysis, particle size distribution, and coating uniformity evaluation. The company follows validated analytical methods and maintains complete traceability across manufacturing processes. Documentation systems are aligned with ICH guidelines, supporting regulatory submissions in Europe, the United States, and emerging global markets.

Customer-Centric Approach to Pellet Manufacturing

From formulation development to commercial-scale production, Credo Life Sciences works closely with pharmaceutical partners to achieve therapeutic, technical, and commercial objectives. Their experienced scientific team collaborates with clients throughout the product lifecycle, ensuring reliable manufacturing support and customised pellet solutions for complex pharmaceutical formulations.